AesRx
AesRx is a biopharmaceutical company dedicated to the development of two novel drugs, Aes-103 and Aes-210, which targets orphan diseases.
AesRx is a company in biopharma, biotechnology, health care based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2008.
Within the biopharma, biotechnology, health care space, the company focuses on its core offering rather than a broad product line.
The business is associated with Greater Boston Area, East Coast, New England, Northeastern US.
It is recorded at the Debt_Financing stage.
Its team size is recorded as c_00001_00010 employees.
Public records show total funding of about $3.5M.
| Sector | Biopharma, Biotechnology, Health Care |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2008 |
| Employees | c_00001_00010 |
| Stage | debt_financing |
| Total funding | $3,455,150 |
Website: www.aesrx.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account